Key result
Cardiac pacing in patients with neurally mediated syncope and documented asystole resulted in a 5% syncope recurrence rate in those with a negative tilt test versus 55% in those with a positive tilt test (P=0.004).
Why the study?
Does cardiac pacing reduce syncope recurrence in patients with presumed neurally mediated syncope and documented asystole, and is this effect modified by tilt test results?
RCT (n=136)
Yes
Does cardiac pacing reduce syncope recurrence in patients with presumed neurally mediated syncope and documented asystole, and is this effect modified by tilt test results?
Absolute Event Rate: 5% vs 55%
p-value: p=0.004
Pacemaker therapy is highly effective in preventing syncope recurrence in patients with neurally mediated syncope and documented asystole who have a negative tilt test, but may lack efficacy in those with a positive tilt test.
Authors
No takes yet. Share an insight, caveat, or question.
Negative tilt test may identify pacing responders in neurally mediated syncope with asystole; leaves open efficacy and requires randomized confirmation.
Brignole et al. (2013) conducted an RCT in Presumed neurally mediated syncope with documented asystole (n=136). Cardiac pacing vs. Tilt test positive patients / untreated controls was evaluated on Syncope recurrence (p=0.004). Cardiac pacing in patients with neurally mediated syncope and documented asystole resulted in a 5% syncope recurrence rate in those with a negative tilt test versus 55% in those with a positive tilt test (P=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: